Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 1 ... in the United States conducted a study "To evaluate the use of prophylactic oral fluconazole in reducing the incidence of tinea gladiatorum in high school wrestlers. A prospective ...
2009 NOV 23 ... subgroup of 103 isolates were subjected to drug susceptibility tests for amphotericin B, fluconazole and ketoconazole by broth microdilution method. A total of 2064 cases of confirmed ...
2009 NOV 16 ... A report, 'Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis,' is newly published data in Clinical and Experimental ...
2009 NOV 1 ... tested against Candida yeast. The inhibition provided by HAMBO was lower than that of fluconazole, showing low antifungal activity against Candida spp., but equivalent to that of ...
2009 NOV 16 ... were treated with an amphotericin B formulation combined in some situations with either fluconazole or itraconazole. underwent treatment with voriconazole for an average of 11 months, with ...
2009 NOV 9 ... According to a study from the United States, "We examined the susceptibilities to fluconazole of 642 bloodstream infection (BSI) isolates of Candida glabrata and grouped the isolates ...
2009 NOV 16 ... researchers in the United States conducted a study "To evaluate the efficacy of fluconazole for the treatment of onychomycosis. Searches of MEDLINE (1966-May 2009) and ...
2009 NOV 16 ... between 1.75 and 2.0 mu g/mL, over 110 days from all bone cements. Flucytosine and fluconazole were observed for 33-42 days before becoming undetectable from a nonbioactive sphere and ...
2009 NOV 9 ... levels of < 11 mu g/mL. The patient with mixed endocarditis was also treated with fluconazole. Two patients initially treated with other antipseudomonal regimens, including cefepime ...
2009 NOV 16 ... spp. and fungicidal activity against most Candida spp., including strains that are fluconazole-resistant. The echinocandins have been shown to be efficacious for the treatment of ...
2009 NOV 1 ... from 92 patients suspected of otomycosis." "The in vitro activity of fluconazole, itraconazole and voriconazole against otomycotic pathogens was tested using the E-test ...
2009 NOV 1 ... cases, respectively, and C. parapsilosis emerged as a predominant species. No fluconazole resistance was observed in C. albicans and C. parapsilosis isolates," wrote N. Al-Sweih ...
2009 NOV 1 ... at least non-inferior to standard treatments. Anidulafungin was shown to be superior to fluconazole. Echinocandins have a favourable tolerability profile and exhibit a minimal potential ...
2009 NOV 1 ... combination with standard concentrations of amphotericin B (AMB), caspofungin (CAS) or fluconazole (FLC), against biofilms formed by Candida albicans in vitro," investigators in the ...
2009 NOV 2 ... and the mutant also displayed increased sensitivities to the antifungal drugs fluconazole and amphotericin B. Wild-type levels of drug sensitivity were restored by the addition ...
2009 NOV 2 ... HEPA-filtered rooms, 84% received oral polyenes, and three aHSCT recipients were given fluconazole. Duration of neutropenia was similar in both treatment groups. Invasive fungal ...
